Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Acta Pharmaceuticals, Inc

Clinical trials sponsored by Acta Pharmaceuticals, Inc, explained in plain language.

Not yet finished but already full! 1

Early safety study of new drug GSM-779690T cancelled before starting

Knowledge-focused Cancelled

This study was designed to test the safety of an experimental drug called GSM-779690T in healthy adults. It was a first-in-human trial with two parts: single and multiple doses. The study was withdrawn before any participants were enrolled, so no results are available.

Phase 1 • Sponsor: Acta Pharmaceuticals, Inc • Aim: Knowledge-focused

Last updated Jun 27, 2026 08:08 UTC